News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ticagrelor Does Not Affect Pulmonary Function in ACS Patients, University of Sheffield Study



10/14/2011 1:33:01 PM

A substudy of the PLATO trial has shown that ticagrelor does not adversely affect pulmonary function in acute coronary syndrome (ACS) patients. This finding comes despite the increased incidence of dyspnea observed with ticagrelor in the main study, remark Robert Storey (University of Sheffield, UK) and co-authors in the American Journal of Cardiology.

Read at Medwire


comments powered by Disqus
Medwire
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES